178 related articles for article (PubMed ID: 28985693)
1. Assessing the depth of isoflurane anaesthesia during cardiopulmonary bypass.
Ng KT; Alston RP; Just G; McKenzie C
Perfusion; 2018 Mar; 33(2):148-155. PubMed ID: 28985693
[TBL] [Abstract][Full Text] [Related]
2. The depth of anaesthesia associated with the administration of isoflurane 2.5% during cardiopulmonary bypass.
Alston RP; Connelly M; MacKenzie C; Just G; Homer N
Perfusion; 2019 Jul; 34(5):392-398. PubMed ID: 30638148
[TBL] [Abstract][Full Text] [Related]
3. Coronary Sinus Isoflurane Concentration in Cardiac Surgery.
Ng KT; Alston RP; Just G; McKenzie C
J Cardiothorac Vasc Anesth; 2017 Dec; 31(6):2035-2041. PubMed ID: 28506542
[TBL] [Abstract][Full Text] [Related]
4. Changes in sevoflurane plasma concentration with delivery through the oxygenator during on-pump cardiac surgery.
Nitzschke R; Wilgusch J; Kersten JF; Trepte CJ; Haas SA; Reuter DA; Goetz AE; Goepfert MS
Br J Anaesth; 2013 Jun; 110(6):957-65. PubMed ID: 23462192
[TBL] [Abstract][Full Text] [Related]
5. A Comparison of the Arterial Blood Concentration of Isoflurane During Cardiopulmonary Bypass Between 2 Polypropylene Oxygenators.
Alston RP; Kitchen C; McKenzie C; Homer N
J Cardiothorac Vasc Anesth; 2020 May; 34(5):1184-1190. PubMed ID: 31548106
[TBL] [Abstract][Full Text] [Related]
6. A comparison of anaesthetic tensions in arterial blood and oxygenator exhaust gas during cardiopulmonary bypass.
Lockwood GG; Sapsed-Byrne SM; Adams S
Anaesthesia; 1999 May; 54(5):434-6. PubMed ID: 10995139
[TBL] [Abstract][Full Text] [Related]
7. In vivo uptake and elimination of isoflurane by different membrane oxygenators during cardiopulmonary bypass.
Wiesenack C; Wiesner G; Keyl C; Gruber M; Philipp A; Ritzka M; Prasser C; Taeger K
Anesthesiology; 2002 Jul; 97(1):133-8. PubMed ID: 12131114
[TBL] [Abstract][Full Text] [Related]
8. Relation between isoflurane concentration, body temperature and EEG variables during hypothermic cardiopulmonary bypass in juvenile sheep.
Otto KA; Höffler HK; Cebotari S; Tudorache I
Vet J; 2011 Jul; 189(1):111-4. PubMed ID: 20630781
[TBL] [Abstract][Full Text] [Related]
9. Monitoring oxygenator expiratory isoflurane concentrations and the bispectral index to guide isoflurane requirements during cardiopulmonary bypass.
Liu EH; Dhara SS
J Cardiothorac Vasc Anesth; 2005 Aug; 19(4):485-7. PubMed ID: 16085254
[TBL] [Abstract][Full Text] [Related]
10. Less isoflurane is required after than before cardiopulmonary bypass to maintain a constant bispectral index value.
Lundell JC; Scuderi PE; Butterworth JF
J Cardiothorac Vasc Anesth; 2001 Oct; 15(5):551-4. PubMed ID: 11687992
[TBL] [Abstract][Full Text] [Related]
11. Sevoflurane and Isoflurane-Pharmacokinetics, Hemodynamic Stability, and Cardioprotective Effects During Cardiopulmonary Bypass.
Freiermuth D; Mets B; Bolliger D; Reuthebuch O; Doebele T; Scholz M; Gregor M; Haschke M; Seeberger MD; Fassl J
J Cardiothorac Vasc Anesth; 2016 Dec; 30(6):1494-1501. PubMed ID: 27692704
[TBL] [Abstract][Full Text] [Related]
12. Effect of anaesthesia and cardiopulmonary bypass on blood endocannabinoid concentrations during cardiac surgery.
Weis F; Beiras-Fernandez A; Hauer D; Hornuss C; Sodian R; Kreth S; Briegel J; Schelling G
Br J Anaesth; 2010 Aug; 105(2):139-44. PubMed ID: 20525978
[TBL] [Abstract][Full Text] [Related]
13. Bispectral index monitoring in patients undergoing cardiac surgery under cardiopulmonary bypass.
Puri GD; Murthy SS
Eur J Anaesthesiol; 2003 Jun; 20(6):451-6. PubMed ID: 12803261
[TBL] [Abstract][Full Text] [Related]
14. Temperature-related differences in mean expired pump and arterial carbon dioxide in patients undergoing cardiopulmonary bypass.
Peng YG; Morey TE; Clark D; Forthofer MD; Gravenstein N; Janelle GM
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):57-60. PubMed ID: 17289481
[TBL] [Abstract][Full Text] [Related]
15. Impact of temperature on the Narcotrend Index during hypothermic cardiopulmonary bypass in children with sevoflurane anesthesia.
Dennhardt N; Beck C; Boethig D; Heiderich S; Horke A; Tiedge S; Boehne M; Sümpelmann R
Perfusion; 2018 May; 33(4):303-309. PubMed ID: 29199541
[TBL] [Abstract][Full Text] [Related]
16. Desflurane pharmacokinetics during cardiopulmonary bypass.
Mets B; Reich NT; Mellas N; Beck J; Park S
J Cardiothorac Vasc Anesth; 2001 Apr; 15(2):179-82. PubMed ID: 11312475
[TBL] [Abstract][Full Text] [Related]
17. Relationship between Sevoflurane Plasma Concentration, Clinical Variables and Bispectral Index Values during Cardiopulmonary Bypass.
Nitzschke R; Wilgusch J; Kersten JF; Goepfert MS
PLoS One; 2015; 10(8):e0134097. PubMed ID: 26312484
[TBL] [Abstract][Full Text] [Related]
18. Isoflurane preconditioning-induced cardio-protection in patients undergoing coronary artery bypass grafting.
Lee MC; Chen CH; Kuo MC; Kang PL; Lo A; Liu K
Eur J Anaesthesiol; 2006 Oct; 23(10):841-7. PubMed ID: 16507192
[TBL] [Abstract][Full Text] [Related]
19. Comparison of SNAP™ II and BIS Vista indices during normothermic cardiopulmonary bypass under isoflurane anesthesia.
Patel KM; Sherwani SS; Fitzgerald PC; McCarthy RJ
J Clin Monit Comput; 2011 Dec; 25(6):365-70. PubMed ID: 22076615
[TBL] [Abstract][Full Text] [Related]
20. Combined use of isoflurane and sodium nitroprusside during active rewarming on cardiopulmonary bypass: a prospective, comparative study.
Ambesh SP; Chattopadhyaya M; Saxena PV; Mahant TS; Ganjoo AK
J Postgrad Med; 2000; 46(4):253-7. PubMed ID: 11435650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
